GLP-1 marketing intelligence wiki
Living reference pages generated from the PulseGLP second brain, reviewed for public-facing aggregate guidance and search discoverability.
Semaglutide vs Tirzepatide Conversation Signals
Patient and market signals PulseGLP tracks when semaglutide and tirzepatide are compared, switched, or positioned.
Before-and-After Weight Loss Ad Risk Guide
A PulseGLP reference for transformation creative, before-and-after framing, and claim-risk patterns in weight loss ads.
GLP-1 Marketing Compliance Guide
A living PulseGLP wiki page on claim patterns, patient language, and ad signals that matter for GLP-1 marketing review.
FDA Warning Letter Patterns in GLP-1 Marketing
Recurring FDA-cited themes PulseGLP tracks across warning letters, scanner findings, and public marketing language.
Compounded GLP-1 Advertising Risk Signals
A living reference for compounded semaglutide and tirzepatide advertising claims, disclosures, and observed ad-market language.
Meta Weight Loss Ad Trends
Observed Meta ad-market patterns around GLP-1, online prescription weight loss, compound positioning, and creative themes.
GLP-1 Side Effect Language Patients Use
A living wiki page for fatigue, nausea, GI symptoms, mood, and other patient-described GLP-1 experience signals.
Food Noise in GLP-1 Patient Conversations
How patients describe food noise, appetite control, cravings, and mental load across PulseGLP evidence sources.